SHUA13014U Translational Pharmacology - From Concept to Medical Drug and from Concept to Biotech Company
MSc Programme in Human Biology - elective
Translational pharmacology describes the process from basic pharmacological research to an approved medical drug, i.e. from idea to a pharmaceutical that can be used in therapy, including a review of the basis for setting up, funding and developing a biotech company based on drug discovery and development.
At the end of the course, students should be able to:
Discuss, analyze and evaluate:
- Drug targets – concept, discovery and validation
- The identification of hits and leads: structure-based drug discovery
- Optimising the medicinal chemistry and testing the properties of target molecules and of ADME properties in vitro and in vivo
- Animal models for testing the effectiveness of medical drugs, PK, and the like
- The development and clinical trials of pharmaceuticals
- Setting up and funding biotech companies based on drug discovery and development – phases in the biotech company lifecycle
- Analysis and comparisons of domestic and international biotech companies based on drug discovery and development
- Category
- Hours
- Exam
- 1
- Lectures
- 35
- Practical exercises
- 16
- Preparation
- 84
- Total
- 136
Open for credit transfer students and other external students. Apply here:
Credit transfer students:
http://healthsciences.ku.dk/education/other-programme-options/credit-transfer-students/
Other external students:
http://healthsciences.ku.dk/education/exchange_guest_students/guest-students/
- Credit
- 5 ECTS
- Type of assessment
- Course participationOral presentation and discussion in course plenum of a case-story in drug-discovery or biotech company establisment and management.
- Exam registration requirements
Participation in all aspects of the course
- Aid
- All aids allowed
- Marking scale
- passed/not passed
- Censorship form
- No external censorship
More than one internal examiner
Criteria for exam assesment
To achieve the grade Passed, the student must adequately be able to:
Discuss, analyze and evaluate:
- Drug targets – concept, discovery and validation
- The identification of hits and leads: structure-based drug discovery
- Optimising the medicinal chemistry and testing the properties of target molecules and of ADME properties in vitro and in vivo
- Animal models for testing the effectiveness of medical drugs, PK, and the like
- The development and clinical trials of pharmaceuticals
- Setting up and funding biotech companies based on drug discovery and development – phases in the biotech company lifecycle
- Analysis and comparisons of domestic and international biotech companies based on drug discovery and development
Course information
- Language
- English
- Course code
- SHUA13014U
- Credit
- 5 ECTS
- Level
- Full Degree Master
- Duration
- 2 weeks
- Placement
- Block 1
Weeks 43-44
- Schedule
- See Syllabus
- Course capacity
- 30 participants. The course is only offered if a minimum of 12 students are registered by the end of the ordinary registration periode: 15th of May – 1st og June.
- Continuing and further education
- Study board
- The Study Board for Human Biology and Immunology
Contracting department
- Department of Neuroscience
Contracting faculty
- Faculty of Health and Medical Sciences
Course Coordinators
- Siv Annegrethe Hjorth (9-756b786a6c7174766a4275777066306d7730666d)